Variables | n * | GG vs. TT | TG vs. TT | GG/TG vs. TT | GG vs. TT/TG | ||||
---|---|---|---|---|---|---|---|---|---|
OR (95% CI) † | P ‡ | OR (95% CI) † | P ‡ | OR (95% CI) † | P ‡ | OR (95% CI) † | P ‡ | ||
Total | 35 | 1.05 (0.95-1.16) | 0.001 | 1.04 (0.96-1.12) | 0.004 | 1.04 (0.97-1.13) | 0.000 | 1.03 (0.96-1.11) | 0.022 |
Ethnicities | |||||||||
Asian | 10 | 1.05 (0.93-1.20) | 0.051 | 0.97 (0.88-1.07) | 0.657 | 0.99 (0.90-1.08) | 0.427 | 1.08 (0.92-1.28) | 0.035 |
European | 23 | 1.05 (0.92-1.19) | 0.001 | 1.09 (0.99-1.20) | 0.003 | 1.09 (0.98-1.21) | 0.000 | 1.00 (0.94-1.07) | 0.062 |
Source of controls | |||||||||
Population-based | 15 | 1.01 (0.92-1.11) | 0.130 | 1.07 (0.95-1.21) | 0.010 | 1.06 (094-1.20) | 0.004 | 0.98 (0.90-1.07) | 0.335 |
Hospital-based | 20 | 1.07 (0.92-1.24) | 0.000 | 1.02 (0.93-1.11) | 0.048 | 1.03 (0.93-1.15) | 0.002 | 1.06 (0.95-1.20) | 0.014 |
Cancer types | |||||||||
Lung cancer | 9 | 1.08 (0.85-1.38) | 0.017 | 0.99 (0.84-1.17) | 0.059 | 1.03 (0.85-1.25) | 0.007 | 1.04 (0.92-1.19) | 0.086 |
Bladder cancer | 7 | 0.96 (0.83-1.09) | 0.312 | 1.01 (0.91-1.12) | 0.376 | 0.99 (0.90-1.10) | 0.453 | 0.95 (0.85-1.07) | 0.360 |
Colorectal cancer | 4 | 0.93 (0.55-1.57) | 0.001 | 1.05 (0.78-1.41) | 0.025 | 1.01 (0.72-1.43) | 0.003 | 0.93 (0.63-1.39) | 0.003 |
Breast cancer | 4 | 1.20 (0.82-1.76) | 0.042 | 1.19 (0.76-1.86) | 0.000 | 1.23 (0.79-1.92) | 0.000 | 1.06 (0.92-1.23) | 0.345 |
Head and neck cancer | 2 | 1.03 (0.80-1.32) | 0.306 | 1.00 (0.81-1.23) | 0.242 | 1.01 (0.83-1.23) | 0.202 | 1.03 (0.83-1.27) | 0.621 |
Others | 9 | 1.07 (0.94-1.23) | 0.156 | 1.05 (0.94-1.16) | 0.754 | 1.05 (0.96-1.16) | 0.609 | 1.05 (0.93-1.18) | 0.111 |